SCHEMBL29516239

SCHEMBL29516239

Cc1cc(C)cc(-c2nc(Cl)cc3ccccc23)c1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.44
CYP2A6 P11509 1/20 0.44
ALDH1A1 P00352 4/20 0.41
KDM4E B2RXH2 3/20 0.41
MAPT P10636 4/20 0.41
ADORA2A P29274 4/20 0.41
ADORA1 P30542 3/20 0.41
LMNA P02545 3/20 0.41
L3MBTL1 Q9Y468 4/20 0.39
BRD9 Q9H8M2 1/20 0.35
BRD7 Q9NPI1 1/20 0.35
MEN1 O00255 1/20 0.34
HPGD P15428 1/20 0.34
KMT2A Q03164 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
CYP1A1 P04798 1/20 0.34
CYP1B1 Q16678 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24287306 1.00 CYP1A2 (0.44) CYP1A2CYP2A6ALDH1A1KDM4EMAPT
SCHEMBL20464228 0.82 KDM4E (0.45) ALDH1A1KDM4EMAPTADORA2ALMNA
SCHEMBL24795340 0.79 CYP1A2 (0.44) CYP1A2CYP2A6ALDH1A1KDM4EMAPT
SCHEMBL15618343 0.79 CASP3 (0.48) CYP1A2CYP2A6ALDH1A1KDM4EMAPT
SCHEMBL28619679 0.76 CYP1A2 (0.44) CYP1A2CYP2A6ALDH1A1KDM4EMAPT
SCHEMBL13316859 0.76 ADORA2A (0.49) CYP1A2CYP2A6ALDH1A1KDM4EMAPT
SCHEMBL29893264 0.76 GPR84 (0.42) ALDH1A1KDM4EMAPTLMNAMEN1
SCHEMBL15860242 0.75 KDM4E (0.73) CYP1A2ALDH1A1KDM4EMAPTADORA2A
SCHEMBL4439497 0.74 CYP2A6 (0.53) CYP1A2CYP2A6ALDH1A1KDM4EMAPT
SCHEMBL30360258 0.74 CYP2A6 (0.53) CYP1A2CYP2A6ALDH1A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225750-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 EP disclosed
WO-2022076629-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 WO disclosed